Effect of alpha-tocopherol and beta-carotene supplementation on macrovascular complications and total mortality from diabetes: Results of the ATBC Study

References

• Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
   PubMed Web of Science ®Google Scholar
• Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Type 2 diabetes as a ‘coronary heart disease equivalent’: an 18-year prospective population-based study in Finnish subjects. Diabetes Care. 2005;28:2901–7.
   PubMed Web of Science ®Google Scholar
• Folsom AR, Rasmussen ML, Chambless LE, Howard G, Cooper LS, Schmidt MI, . Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke. Diabetes Care. 1999;22:1077–83.
   PubMed Web of Science ®Google Scholar
• Chertow B. Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications. MedGenMed. 2004;6 Suppl 3:S4.
   Google Scholar
• Pennathur S, Heinecke JW. Mechanisms for oxidative stress in diabetic cardiovascular disease. Antioxid Redox Signal. 2007;9:955–69.
   PubMed Web of Science ®Google Scholar
• Jay D, Hitomi H, Griendling KK. Oxidative stress and diabetic cardiovascular complications. Free Radic Biol Med. 2006;40:183–92.
   PubMedGoogle Scholar
• Carr AC, Zhu BZ, Frei B. Potential antiatherogenic mechanisms of ascorbate (vitamin C) and alpha-tocopherol (vitamin E). Circ Res. 2000;87:349–54.
   PubMed Web of Science ®Google Scholar
• Tsuchihashi H, Kigoshi M, Iwatsuki M, Niki E. Action of beta-carotene as an antioxidant against lipid peroxidation. Arch Biochem Biophys. 1995;323:137–47.
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Hoogwerf B, Poque J, Yi Q, Zinman B, . Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care. 2002;25:1919–27.
   PubMed Web of Science ®Google Scholar
• Sacco M, Pellegrini F, Roncaglioni MC, Avanzini FM, Tognoni G, Nicolucci A. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003;26:3264–72.
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:23–33.
   PubMed Web of Science ®Google Scholar
• Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFayden J, Danielson E, . A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women’s Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610–8.
   PubMed Web of Science ®Google Scholar
• Lee IM, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, . Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women’s Health Study: a randomized controlled trial. JAMA. 2005;294:56–65.
   PubMed Web of Science ®Google Scholar
• Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFayden J, . Vitamins E and C in the Prevention of Cardiovascular Disease in Men, The Physicians’ Health Study II Randomized Controlled Trial. JAMA. 2008;300: 2123–33.
   PubMed Web of Science ®Google Scholar
• The Alpha-Tocopherol, Beta-Carotene Lung Cancer Prevention Study: design, methods, participant characteristics and compliance. The ATBC Cancer Prevention Study Group. Ann Epidemiol. 1994;4:1–10.
   PubMedGoogle Scholar
• Rapola JM, Virtamo J, Korhonen P, Haapakoski J, Hartman AM, Edwards BK, . Validity of diagnoses of major coronary events in national registers of hospital diagnoses and deaths in Finland. Eur J Epidemiol. 1997;13:133–8.
   PubMed Web of Science ®Google Scholar
• Leppälä JM, Virtamo J, Heinonen OP. Validation of stroke diagnosis in the National Hospital Discharge Register and the Register of Causes of Death in Finland. Eur J Epidemiol. 1999;15:155–60.
   Google Scholar
• Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81: 515–26.
   Web of Science ®Google Scholar
• Levy AP, Gerstein HC, Miller-Lotan R, Ratner R, McQueen M, Lonn E, . The effect of vitamin E supplementation on cardiovascular risk in diabetic individuals with different haptoglobin phenotypes. Diabetes Care. 2004;27:2767.
   PubMed Web of Science ®Google Scholar
• Milman U, Blum S, Shapira C, Aronson D, Miller-Lotan R, Anbinder Y, . Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype. A prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008;28:341–7.
   PubMed Web of Science ®Google Scholar
• Albanes A, Heinonen OP, Taylor PR, Virtamo J, Edwards BK, Rautalahti M, . α-Tocopherol and β-carotene supplements and lung cancer incidence in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study: Effects of base-line characteristics and study compliance. J Natl Cancer Inst. 1996;88:1560–70.
   PubMed Web of Science ®Google Scholar
• Omenn GS, Goodmann GE, Thornquist MD, Balmes J, Cullen MR, Glass A, . Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial. J Natl Cancer Inst. 1996;88:1550–9.
   PubMed Web of Science ®Google Scholar
• Dietary Reference Intake. A Report of the Panel on Micronutrients, Subcommittees on Upper Reference Levels of Nutrients and of Interpretation and Uses of Dietary Reference Intakes, and the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Washington, DC: National Academy Press; 2001.
   Google Scholar